These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 35151372)

  • 1. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Projected Fatal Overdose Outcomes and Costs of Strategies to Expand Community-Based Distribution of Naloxone in Rhode Island.
    Zang X; Bessey SE; Krieger MS; Hallowell BD; Koziol JA; Nolen S; Behrends CN; Murphy SM; Walley AY; Linas BP; Schackman BR; Marshall BDL
    JAMA Netw Open; 2022 Nov; 5(11):e2241174. PubMed ID: 36350649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.
    Taylor M; Pradhan A; Ogando YM; Shaya F
    Am J Drug Alcohol Abuse; 2022 May; 48(3):338-346. PubMed ID: 35467459
    [No Abstract]   [Full Text] [Related]  

  • 7. Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin.
    Coffin PO; Maya S; Kahn JG
    Drug Alcohol Depend; 2022 Jul; 236():109478. PubMed ID: 35588609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Naloxone Coprescribing Mandates on Opioid-Involved Overdose Deaths.
    Sohn M; Delcher C; Talbert JC; Cheng Y; Xu Y; Jadhav ED; Freeman PR
    Am J Prev Med; 2023 Apr; 64(4):483-491. PubMed ID: 36496279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
    Fairbairn N; Coffin PO; Walley AY
    Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
    Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
    JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states.
    Bruzelius E; Cerdá M; Davis CS; Jent V; Wheeler-Martin K; Mauro CM; Crystal S; Keyes KM; Samples H; Hasin DS; Martins SS
    Int J Drug Policy; 2023 Apr; 114():103980. PubMed ID: 36863285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study.
    Antoniou T; Men S; Tadrous M; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2022 Jul; 236():109473. PubMed ID: 35523113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
    Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
    Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
    [No Abstract]   [Full Text] [Related]  

  • 15. An individual-based dynamic model to assess interventions to mitigate opioid overdose risk.
    Gallant K; Lukeman R
    Harm Reduct J; 2024 Aug; 21(1):146. PubMed ID: 39135022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid Settlement.
    Zang X; Skinner A; Krieger MS; Behrends CN; Park JN; Green TC; Walley AY; Morgan JR; Linas BP; Yedinak JL; Schackman BR; Marshall BDL
    JAMA Netw Open; 2024 May; 7(5):e2413861. PubMed ID: 38814644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fentanyl harm reduction strategies among Latinx communities in the United States: a scoping review.
    Luna G; Dermid G; Unger JB
    Harm Reduct J; 2024 Aug; 21(1):150. PubMed ID: 39152433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
    Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
    CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
    Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD
    Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.